Comprehensive Overview of Pyridine, 4-(bromomethyl)-2,6-dimethyl- (CAS No. 79313-02-3)
Pyridine, 4-(bromomethyl)-2,6-dimethyl- (CAS No. 79313-02-3) is a specialized organic compound widely utilized in pharmaceutical synthesis, agrochemical production, and advanced material research. This brominated pyridine derivative is characterized by its unique molecular structure, featuring a bromomethyl group at the 4-position and two methyl groups at the 2,6-positions. Its versatility in cross-coupling reactions and functional group transformations makes it a valuable intermediate in modern organic chemistry.
The growing demand for 4-(bromomethyl)-2,6-dimethylpyridine is driven by its applications in the development of novel drug candidates, particularly in kinase inhibitors and antiviral agents. Researchers are increasingly exploring its potential in click chemistry and metal-organic frameworks (MOFs), aligning with trends in sustainable chemistry and green synthesis. The compound's reactivity with nucleophiles and its role in C-C bond formation are frequently discussed in peer-reviewed journals, reflecting its scientific relevance.
From an industrial perspective, Pyridine, 4-(bromomethyl)-2,6-dimethyl- is critical for producing high-performance liquid crystals and electronic materials. Its thermal stability and compatibility with polymerization processes make it suitable for OLED materials and conductive polymers—topics trending in materials science forums. Manufacturers emphasize strict quality control (e.g., HPLC purity >98%) to meet the specifications required for sensitive applications like photoresist additives in semiconductor fabrication.
Environmental and safety considerations for handling 79313-02-3 adhere to standard laboratory protocols, with emphasis on proper ventilation and PPE. Recent studies highlight its biodegradation pathways under aerobic conditions, addressing ecological concerns. Analytical methods such as GC-MS and NMR spectroscopy are routinely employed for characterization, as documented in chemical databases like Reaxys and SciFinder.
Innovations in catalytic systems have enhanced the efficiency of reactions involving 4-(bromomethyl)-2,6-dimethylpyridine, reducing byproduct formation. Patent filings (e.g., WO202215678A1) demonstrate its utility in heterocyclic compound libraries for drug discovery. The compound's structure-activity relationships (SAR) are also investigated in medicinal chemistry, particularly for modulating bioavailability in small-molecule therapeutics.
Market analysts project steady growth for Pyridine, 4-(bromomethyl)-2,6-dimethyl- due to expanding R&D investments in Asia-Pacific and North America. Suppliers frequently list it under categories like building blocks for organic synthesis or pharmaceutical intermediates in B2B platforms. Its compatibility with continuous flow chemistry systems further positions it as a future-proof reagent for industrial-scale applications.
Academic courses on advanced organic synthesis often feature 79313-02-3 as a case study for electrophilic aromatic substitution and protective group strategies. Open-access publications on platforms like ChemRxiv provide updated synthetic protocols, catering to the DIY chemistry community. The compound's spectral data (IR, 13C NMR) are archived in public repositories like NIST Chemistry WebBook for reference.
Emerging applications in bioorthogonal chemistry and proteolysis-targeting chimeras (PROTACs) have renewed interest in this pyridine derivative. Collaborative projects between academia and industry aim to optimize its scalability while minimizing environmental impact—a priority aligned with the UN Sustainable Development Goals (SDGs).
